Release Date: 07/05/15 09:55 Summary: Newzulu signs deal with Tribune Price Sensitive: Yes Download Document 28.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%